According to research published today in the iNew England Journal of Medicine/i (1) a 48-week course of antiretroviral medication taken in the early stages of HIV infection slows the damage to the immune system and delays the need for long term treatment. However, the delay was only marginally longer than the time already spent on treatment. The study, the largest clinical trial ever undertaken looking at treating people with recent HIV infection, also suggests ...Saturday 19 January 2013
Research: Early Treatment for HIV Slows Damage to Immune System and Reduces Risk of Transmission
According to research published today in the iNew England Journal of Medicine/i (1) a 48-week course of antiretroviral medication taken in the early stages of HIV infection slows the damage to the immune system and delays the need for long term treatment. However, the delay was only marginally longer than the time already spent on treatment. The study, the largest clinical trial ever undertaken looking at treating people with recent HIV infection, also suggests ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment